Exclusive: Spiderman Takes Over as AbbVie's New CEO

Swinging into Succession

So guess who's the new CEO of AbbVie? Yep you're looking at him Spiderman! Well okay maybe not the one you were expecting but Robert Michael is taking over from Richard Gonzalez in this epic executive web slinging transition.

Web of Challenges

AbbVie is facing some tough battles in the pharmaceutical world especially with Humira facing off against some fresh biosimilar competition. But fear not because Spiderman's got a couple of his own superhero drugs in the form of Skyrizi and Rinvoq to save the day!

From C suite Climber to CEO

Michael has been honing his skills in the C suite for over a decade making moves like acquiring neuroscience drugmaker Cerevel Therapeutics and cancer drug developer ImmunoGen. Looks like he's ready to swing into action as AbbVie's CEO.

Exciting Times Ahead

With $16 billion in sales expected this year and a whopping $27 billion projected for 2027 things are looking up for AbbVie under Spiderman...I mean Robert Michael's leadership. Looks like the future is bright in this pharmaceutical superhero saga!